Caxton Associates (New York)’s Codexis CDXS Stock Holding History
Bought
Maintained
Sold
Other funds holding CDXS
NCM
TAM
N
Caxton Associates (New York)'s CDXS Position: Q3 2023 in Review
Caxton Associates (New York) sold out of Codexis (CDXS) in Q3 2023, closing a stake of 29,121 shares — an estimated $81.5K sold.
Caxton Associates (New York) first reported a position in CDXS in Q4 2022 and held it in 3 quarters. The position peaked at $136K in Q4 2022. 122 funds tracked by Wall St. Rank hold CDXS as of Q3 2023.
- Caxton Associates (New York) reported no remaining Codexis position as of Q3 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 29,121 Codexis shares in Q3 2023, an estimated $81.5K.
- Caxton Associates (New York) first reported a position in Codexis in Q4 2022 and held it in 3 quarters.
- Caxton Associates (New York)'s Codexis position peaked at $136K in Q4 2022.
- 122 funds tracked by Wall St. Rank held Codexis as of Q3 2023.
Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.